174 related articles for article (PubMed ID: 11165318)
1. Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer.
Oba K; Matsuyama H; Yoshihiro S; Kishi F; Takahashi M; Tsukamoto M; Kinjo M; Sagiyama K; Naito K
Cancer Genet Cytogenet; 2001 Jan; 124(1):20-6. PubMed ID: 11165318
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
[TBL] [Abstract][Full Text] [Related]
3. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization.
Matsuyama H; Pan Y; Skoog L; Tribukait B; Naito K; Ekman P; Lichter P; Bergerheim US
Oncogene; 1994 Oct; 9(10):3071-6. PubMed ID: 8084616
[TBL] [Abstract][Full Text] [Related]
4. Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3.
Suzuki H; Emi M; Komiya A; Fujiwara Y; Yatani R; Nakamura Y; Shimazaki J
Genes Chromosomes Cancer; 1995 Jul; 13(3):168-74. PubMed ID: 7669736
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
[TBL] [Abstract][Full Text] [Related]
6. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.
Kagan J; Stein J; Babaian RJ; Joe YS; Pisters LL; Glassman AB; von Eschenbach AC; Troncoso P
Oncogene; 1995 Nov; 11(10):2121-6. PubMed ID: 7478532
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.
Macoska JA; Trybus TM; Sakr WA; Wolf MC; Benson PD; Powell IJ; Pontes JE
Cancer Res; 1994 Jul; 54(14):3824-30. PubMed ID: 8033102
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer.
Matsuyama H; Pan Y; Yoshihiro S; Kudren D; Naito K; Bergerheim US; Ekman P
Prostate; 2003 Feb; 54(2):103-11. PubMed ID: 12497583
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.
Wagner U; Bubendorf L; Gasser TC; Moch H; Görög JP; Richter J; Mihatsch MJ; Waldman FM; Sauter G
Am J Pathol; 1997 Sep; 151(3):753-9. PubMed ID: 9284824
[TBL] [Abstract][Full Text] [Related]
11. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma.
Yamaguchi S; Yoshihiro S; Matsuyama H; Nagao K; Fukunaga K; Matsumoto H; Matsuda K; Oba K; Naito K
Clin Genet; 2003 Mar; 63(3):184-91. PubMed ID: 12694227
[TBL] [Abstract][Full Text] [Related]
12. Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer.
Kurimoto F; Gemma A; Hosoya Y; Seike M; Takenaka K; Uematsu K; Yoshimura A; Shibuya M; Kudoh S
Int J Mol Med; 2001 Jul; 8(1):89-93. PubMed ID: 11408955
[TBL] [Abstract][Full Text] [Related]
13. Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer.
Matsuyama H; Pan Y; Oba K; Yoshihiro S; Matsuda K; Hägarth L; Kudren D; Naito K; Bergerheim US; Ekman P
Clin Cancer Res; 2001 Oct; 7(10):3139-43. PubMed ID: 11595707
[TBL] [Abstract][Full Text] [Related]
14. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.
Macoska JA; Trybus TM; Benson PD; Sakr WA; Grignon DJ; Wojno KD; Pietruk T; Powell IJ
Cancer Res; 1995 Nov; 55(22):5390-5. PubMed ID: 7585607
[TBL] [Abstract][Full Text] [Related]
15. Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer.
Matsuyama H; Oba K; Matsuda K; Yoshihiro S; Tsukamoto M; Kinjo M; Sagiyama K; Takei M; Yamaguchi A; Sasaki K; Naito K
Cancer Genet Cytogenet; 2007 Apr; 174(1):24-34. PubMed ID: 17350463
[TBL] [Abstract][Full Text] [Related]
16. Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines.
König JJ; Teubel W; van Steenbrugge GJ; Romijn JC; Hagemeijer A
Urol Res; 1999; 27(1):3-8. PubMed ID: 10092147
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer.
Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA
Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452
[TBL] [Abstract][Full Text] [Related]
18. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
19. Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3.
Cunningham C; Dunlop MG; Wyllie AH; Bird CC
Oncogene; 1993 May; 8(5):1391-6. PubMed ID: 8479756
[TBL] [Abstract][Full Text] [Related]
20. Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer.
Swalwell JI; Vocke CD; Yang Y; Walker JR; Grouse L; Myers SH; Gillespie JW; Bostwick DG; Duray PH; Linehan WM; Emmert-Buck MR
Genes Chromosomes Cancer; 2002 Feb; 33(2):201-5. PubMed ID: 11793446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
